McKesson (NYSE:MCK) Issues Q2 2025 Earnings Guidance

McKesson (NYSE:MCK) updated its second quarter 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 6.700-7.000 for the period, compared to the consensus estimate of 7.240. The company issued revenue guidance of -.

McKesson Trading Down 2.1 %

McKesson stock traded down $10.58 during midday trading on Friday, reaching $504.17. 1,924,323 shares of the stock traded hands, compared to its average volume of 761,035. The firm has a market cap of $65.51 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 1.29 and a beta of 0.44. The company has a 50-day simple moving average of $574.75 and a two-hundred day simple moving average of $557.29. McKesson has a 12-month low of $412.64 and a 12-month high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, beating the consensus estimate of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. During the same quarter last year, the firm posted $7.27 earnings per share. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that McKesson will post 32.14 earnings per share for the current year.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be given a dividend of $0.71 per share. The ex-dividend date is Friday, August 30th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.56%. This is a positive change from McKesson’s previous quarterly dividend of $0.62. McKesson’s dividend payout ratio is currently 12.69%.

Analysts Set New Price Targets

Several brokerages have weighed in on MCK. StockNews.com downgraded McKesson from a strong-buy rating to a buy rating in a report on Friday, August 9th. JPMorgan Chase & Co. raised their target price on shares of McKesson from $656.00 to $661.00 and gave the company an overweight rating in a report on Wednesday, August 21st. Robert W. Baird lowered their price target on shares of McKesson from $694.00 to $671.00 and set an outperform rating for the company in a report on Thursday, August 8th. Citigroup increased their price objective on shares of McKesson from $620.00 to $670.00 and gave the company a buy rating in a research report on Friday, July 19th. Finally, Evercore ISI decreased their price objective on shares of McKesson from $660.00 to $630.00 and set an outperform rating for the company in a research report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $624.93.

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $580.92, for a total value of $2,180,192.76. Following the transaction, the chief executive officer now directly owns 86,092 shares of the company’s stock, valued at approximately $50,012,564.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Leann B. Smith sold 600 shares of the stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $585.53, for a total transaction of $351,318.00. Following the completion of the sale, the executive vice president now directly owns 2,022 shares of the company’s stock, valued at $1,183,941.66. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $580.92, for a total transaction of $2,180,192.76. Following the completion of the transaction, the chief executive officer now owns 86,092 shares in the company, valued at $50,012,564.64. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,859 shares of company stock valued at $6,986,810. 0.11% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.